We studied the effect of IGF-1 and EGF treatment on the degree of extracellular (i.e. secreted) MMP activity which could explain how these growth factors can enhance the invasion of endocrine resistant breast cancer cells as indicated by the data in Figs. 4 and 5. The gene discussed is IGF1; the disease is breast carcinoma.